Leading the Way in Life Science Technologies

GEN Exclusives

More »

Best of the Web

More »
Oct 01, 2005 (Vol. 25, No. 17)

Society for In Vitro Biology

URL:www.sivb.org
  • Miscellaneous tidbits
  • Not very broad
I’m always a little hesitant about reviewing pages for professional societies because most of them are pretty boring. This one too, has its less-than-scintillating moments (committee listings, bylaws, etc.), but I guess those are excusable if they are serving the membership. What brings the Society for In Vitro Biology’s site into focus here are the elements of it that serve a much broader audience. There are several of these, including a well-written paper on terminology associated with tissue culture, a listing of job postings, a book/movie shelf for sale/rent, and a few useful links. It’s not going to win any prizes for breadth (which is a shame, given the topic), but the site is at least worth a look-see.
  • Key:
  • Strong Points
  • Weak Points
  • Ratings:
  • Excellent
  • Very Good
  • Good


*The opinions expressed are solely those of the author(s) and should not be construed as reflecting the viewpoints of the publisher, Genetic Engineering & Biotechnology News, Mary Ann Liebert, Inc., the publishing house, or employees and affiliates thereof.

Be sure to take the GEN Poll

Scientifically Studying Ecstasy

MDMA (commonly known as the empathogen “ecstasy”) is classified as a Schedule 1 drug, which is reserved for compounds with no accepted medical use and a high abuse potential. Two researchers from Stanford, however, call for a rigorous scientific exploration of MDMA's effects to identify precisely how the drug works, the data from which could be used to develop therapeutic compounds.

Do you agree that ecstasy should be studied for its potential therapeutic benefits?

More »